We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.01B
AUM Growth
-$366M
Cap. Flow
-$36.9M
Cap. Flow %
-1.23%
Top 10 Hldgs %
25.25%
Holding
347
New
17
Increased
116
Reduced
121
Closed
20

Top Buys

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$15M
2
VERX icon
Vertex
VERX
+$11.6M
3
CSGP icon
CoStar Group
CSGP
+$10.7M
4
FTAI icon
FTAI Aviation
FTAI
+$10.6M
5
CCB icon
Coastal Financial
CCB
+$9.84M

Sector Composition

Rank Sector Weight
1 Technology 28.33%
2 Financials 16.99%
3 Healthcare 15.27%
4 Consumer Discretionary 13.43%
5 Industrials 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONON icon
101
On Holding
ONON
$10.3B
$8.04M 0.27%
183,070
+6,114
+3% +$321K
ADMA icon
102
ADMA Biologics
ADMA
$2.22B
$8M 0.27%
403,141
-33,056
-8% -$572K
NCNO icon
103
nCino
NCNO
$2.1B
$7.94M 0.26%
289,168
+9,283
+3% +$294K
FLOC
104
Flowco Holdings
FLOC
$973M
$7.83M 0.26%
+305,154
New +$8.05M
QTWO icon
105
Q2 Holdings
QTWO
$3.95B
$7.78M 0.26%
+97,219
New +$8.58M
GBCI icon
106
Glacier Bancorp
GBCI
$6.39B
$7.75M 0.26%
+175,348
New +$8.45M
MYRG icon
107
MYR Group
MYRG
$5.14B
$7.75M 0.26%
68,531
+2,309
+3% +$307K
AORT icon
108
Artivion
AORT
$1.38B
$7.65M 0.25%
+311,224
New +$8.64M
AGYS icon
109
Agilysys
AGYS
$3.01B
$7.57M 0.25%
+104,332
New +$9.54M
FCN icon
110
FTI Consulting
FCN
$4.22B
$7.55M 0.25%
46,043
-27,580
-37% -$4.96M
CFLT
111
DELISTED
Confluent
CFLT
$7.53M 0.25%
321,037
+10,725
+3% +$311K
PHR icon
112
Phreesia
PHR
$758M
$7.44M 0.25%
291,127
-28,200
-9% -$767K
WNC icon
113
Wabash National
WNC
$505M
$7.44M 0.25%
673,193
+11,934
+2% +$160K
FOLD
114
DELISTED
Amicus Therapeutics
FOLD
$7.43M 0.25%
910,508
+29,991
+3% +$278K
S icon
115
SentinelOne
S
$7.7B
$7.41M 0.25%
407,792
+13,483
+3% +$293K
PRVA icon
116
Privia Health
PRVA
$2.81B
$7.41M 0.25%
330,130
+9,362
+3% +$218K
VVV icon
117
Valvoline
VVV
$4.21B
$7.38M 0.24%
211,880
+7,123
+3% +$260K
P
118
Everpure Inc
P
$36.4B
$7.29M 0.24%
164,595
+5,503
+3% +$332K
RBA icon
119
RB Global
RBA
$16.6B
$7.28M 0.24%
72,607
+2,097
+3% +$200K
LITE icon
120
Lumentum
LITE
$63.8B
$7.26M 0.24%
116,408
+825
+0.7% +$63.5K
BCC icon
121
Boise Cascade
BCC
$2.98B
$7.15M 0.24%
72,922
+2,313
+3% +$262K
ASO icon
122
Academy Sports + Outdoors
ASO
$3.07B
$7.02M 0.23%
153,807
+18,937
+14% +$973K
AXSM icon
123
Axsome Therapeutics
AXSM
$11.1B
$6.97M 0.23%
59,721
-27,466
-32% -$3.13M
SWTX
124
DELISTED
SpringWorks Therapeutics
SWTX
$6.96M 0.23%
157,671
-3,515
-2% -$162K
KNSA icon
125
Kiniksa Pharmaceuticals
KNSA
$6.07B
$6.87M 0.23%
309,190
+65,147
+27% +$1.34M

Similar funds

Peregrine Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Peregrine Capital Management held 347 positions worth $3.01B, down 11% from $3.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Peregrine Capital Management's Q1 2025 filing shows 17 new, 116 increased, 121 reduced and 20 closed positions. Its largest new stake was Vertex: 254,894 shares worth $8.92M. The largest sale was DoubleVerify, an estimated $26.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.

  • Peregrine Capital Management's largest Q1 2025 buy was Vertex: 254,894 shares worth $8.92M.
  • Peregrine Capital Management added most to Trade Desk in Q1 2025, an estimated $15M increase.
  • Peregrine Capital Management's biggest Q1 2025 reduction was DoubleVerify, cutting an estimated $26.4M.
  • Peregrine Capital Management fully exited Flywire in Q1 2025, selling an estimated $10.1M.
  • Peregrine Capital Management's ten largest holdings make up 25% of its $3.01B portfolio in Q1 2025.
  • Peregrine Capital Management opened 17 new positions and closed 20 in Q1 2025.
  • Peregrine Capital Management's portfolio value fell 11% quarter-over-quarter to $3.01B.

Based on Peregrine Capital Management's 13F filing for Q1 2025, filed 25 Apr 2025.